# Oral Dosage Form New Animal Drugs; Orbifloxacin
> **Food and Drug Administration** · Final rule. · Published 2006-03-23 · Effective 2006-03-23 · 71 FR 14642
## Document
- **Document number:** 06-2791
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 71 FR 14642
- **CFR reference:** 21 CFR 520
- **Publication date:** 2006-03-23
- **Effective date:** 2006-03-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The supplemental NADA provides for revised animal safety labeling for orbifloxacin tablets used in dogs and cats for the management of diseases associated with susceptible bacteria.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2006/03/23/06-2791/oral-dosage-form-new-animal-drugs-orbifloxacin)
---
*AI Analytics · CC0 1.0*